Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

Table 2

Patient characteristics.

Characteristics	Patients (n = 87)		Percentage (%)
Age (mean, range)	53.1 ± 12.4 (35–71)
≥60	53		61
<60	34		39
Sex
Male	57		66
Female	30		34
ECOG performance status
0	53		61
1	34		39
HBV infection
Yes	56		64
No	31		36
Cirrhosis
Yes	49		56
No	38		44
Child–Pugh class
A	52		60
B	35		40
AFP level
≤400 ng/mL	50		57
>400 ng/mL	37		43
PVTT
Absent	60		69
Present	27		31
Tumour location
Left	24		28
Right	41		47
Both	22		25
Tumour burden
≤50%	52		60
>50%	35		40
Dosage of apatinib (mg)
250	9		10
500	78		90

ECOG, Eastern Cooperative Oncology Group; AFP, alpha-fetoprotein; data are numbers of events.